Nasdaq · Financials
Health In Tech, Inc. (HIT)
As-reported financials and recent SEC filings for Health In Tech, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$33.3M
Net income
$1.3M
Net margin
3.8%
Diluted EPS
$0.02
ROE
7.5%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | $33.3M | $19.5M | $19.2M |
| Gross profit | $20.9M | $15.4M | $16.8M |
| Operating income | — | — | — |
| Net income | $1.3M | $670,477 | $4.0M |
| Diluted EPS | $0.02 | $0.01 | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
S-3/A2026-06-26
View on EDGAR →424B32026-06-24
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →EFFECT2026-06-10
View on EDGAR →S-32026-06-10
View on EDGAR →42026-05-22
View on EDGAR →Largest Financials peers
Go deeper on HIT
Search Health In Tech, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.